Published in PLoS One on February 16, 2012
HIV-1 genetic diversity in Russia: CRF63_02A1, a new HIV type 1 genetic variant spreading in Siberia. AIDS Res Hum Retroviruses (2014) 0.82
HIV Transmission Patterns Among Immigrant Latinos Illuminated by the Integration of Phylogenetic and Migration Data. AIDS Res Hum Retroviruses (2015) 0.77
Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland. J Int AIDS Soc (2014) 0.77
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol (2007) 168.76
BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol (2007) 74.13
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol (2010) 53.37
Relaxed phylogenetics and dating with confidence. PLoS Biol (2006) 37.68
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol (1999) 18.82
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One (2009) 8.37
Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis (2006) 5.90
Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med (2008) 4.76
Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis (2008) 4.48
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS (2007) 3.94
Bioinformatics prediction of HIV coreceptor usage. Nat Biotechnol (2007) 3.64
Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci U S A (2005) 3.04
HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis (2007) 2.87
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis (2002) 2.54
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid. AIDS (2002) 2.36
Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. J Infect Dis (2007) 2.21
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol (2007) 2.14
Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog (2009) 2.10
Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis (2009) 1.96
HIV-1 subtypes: epidemiology and significance for HIV management. Curr Opin Infect Dis (2006) 1.92
Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS (2008) 1.89
Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc (2010) 1.87
Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS (2004) 1.82
HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr (2010) 1.74
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS (2008) 1.74
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol (2000) 1.70
Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naïve individuals. J Virol (2009) 1.70
Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr (2007) 1.64
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64
Epidemiological study of phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between subtype B and non-B infections. BMC Infect Dis (2010) 1.64
Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. AIDS (2007) 1.63
Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc. Clin Infect Dis (2011) 1.53
HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS (1998) 1.50
Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis (2001) 1.28
Phylogenetic investigation of transmission pathways of drug-resistant HIV-1 utilizing pol sequences derived from resistance genotyping. J Acquir Immune Defic Syndr (2008) 1.17
Genotypic prediction of HIV-1 subtype D tropism. Retrovirology (2011) 1.16
Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res Hum Retroviruses (2001) 1.08
Using phylogeography to characterize the origins of the HIV-1 subtype F epidemic in Romania. Infect Genet Evol (2011) 1.07
Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. AIDS Res Hum Retroviruses (2004) 1.02
The epidemic of human immunodeficiency virus infection in Romanian children. AIDS Res Hum Retroviruses (1993) 1.01
Molecular phylogenetics of transmitted drug resistance in newly diagnosed HIV Type 1 individuals in Denmark: a nation-wide study. AIDS Res Hum Retroviruses (2011) 0.99
Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. AIDS Res Hum Retroviruses (2003) 0.97
[Late AIDS diagnosis in patients hospitalized in Clinic of Infectious Diseases and Hepatology PAM in years 2003-2007]. Przegl Epidemiol (2009) 0.95
Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis. J Acquir Immune Defic Syndr (2009) 0.93
Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece. J Antimicrob Chemother (2011) 0.93
HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain. J Acquir Immune Defic Syndr (2009) 0.92
HIV-1 nef protein structures associated with brain infection and dementia pathogenesis. PLoS One (2011) 0.91
Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS). Antiviral Res (2011) 0.90
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. HIV Med (2010) 0.90
Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection. J Clin Microbiol (2010) 0.86
Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008. J Med Virol (2010) 0.83
Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals. AIDS Res Hum Retroviruses (2011) 0.82
A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes. J Virol Methods (2008) 0.82
Characteristics of HIV-1 non-B subtype infections in Northwest Poland. J Med Virol (2010) 0.81
[Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland]. Przegl Epidemiol (2007) 0.81
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. Infect Agent Cancer (2008) 0.81
[HIV and AIDS in Poland in 2009]. Przegl Epidemiol (2011) 0.79
HIV-1 subtype J recombinant viruses in Spain. AIDS Res Hum Retroviruses (2002) 0.78
Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples. AIDS Res Hum Retroviruses (2004) 0.78
Risk of all-cause mortality in HIV infected patients is associated with clinical, immunologic predictors and the CCR5 Δ32 deletion. PLoS One (2011) 0.77
Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010. Virol J (2011) 0.77
[Late AIDS diagnosis in patients hospitalized in Clinic of Infectious Diseases and Hepatology PAM in years 2003-2007]. Przegl Epidemiol (2009) 0.95
Distribution of HCV genotypes in Poland. Przegl Epidemiol (2013) 0.91
Risk factors and dynamics of weight gain in patients after liver transplantation. Ann Transplant (2009) 0.90
[Relationship of serum alanine aminotransferase (ALT) to body weight, age and sex in blood donors population]. Wiad Lek (2004) 0.85
Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008. J Med Virol (2010) 0.83
IL28B CC genotype is associated with higher all-cause mortality in antiretroviral-treated HIV-infected patients. AIDS Res Hum Retroviruses (2012) 0.82
[Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations]. Pol Merkur Lekarski (2010) 0.82
Characteristics of HIV-1 non-B subtype infections in Northwest Poland. J Med Virol (2010) 0.81
Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B. Przegl Epidemiol (2013) 0.80
[Standards of hepatitis C treatment. Recommendations of Polish Group of Experts]. Przegl Epidemiol (2012) 0.78
State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin. Hepatogastroenterology (2008) 0.78
[Serum leptin and adiponectin concentrations in patients infected with human immunodeficiency virus type 1 (HIV-1) on antiretroviral therapy]. Endokrynol Pol (2005) 0.77
[Increased incidence of hepatocellular carcinoma]. Pol Merkur Lekarski (2002) 0.77
Risk of all-cause mortality in HIV infected patients is associated with clinical, immunologic predictors and the CCR5 Δ32 deletion. PLoS One (2011) 0.77
HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland. BMC Infect Dis (2012) 0.76
Comparative effects of conjugated linoleic acid (CLA) and linoleic acid (LA) on the oxidoreduction status in THP-1 macrophages. J Agric Food Chem (2011) 0.76
[Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)]. Przegl Epidemiol (2005) 0.76
Pathologist and HIV--are safe autopsies possible? Pol J Pathol (2003) 0.76
Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016. Clin Exp Hepatol (2016) 0.75
Hypertension, dyslipidemia and cardiovascular risk in HIV infected adults in Poland. Kardiol Pol (2017) 0.75
Occupational exposure to human immunodeficiency virus (HIV)--how can we reduce the risk? Int J Occup Saf Ergon (2004) 0.75
[Peginterferon alpha-2b in patients with chronic hepatitis C]. Pol Merkur Lekarski (2004) 0.75
Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clin Exp Hepatol (2015) 0.75
[Occupational exposure to HIV among Polish surgeons from the province of West Pomerania]. Pol Merkur Lekarski (2003) 0.75
[The characteristics of staphylococcal enterotoxins produced by strains isolated from mastitic cows, including epidemiological aspects]. Przegl Epidemiol (2005) 0.75
[Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)]. Przegl Epidemiol (2011) 0.75
Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015. Przegl Epidemiol (2015) 0.75
Genotypic tropism of antiretroviral-treated patients with drug resistant HIV-1. J Med Virol (2011) 0.75
[Evaluation of quality of HIV diagnostic procedures in Poland]. Przegl Epidemiol (2010) 0.75
[Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection]. Przegl Epidemiol (2010) 0.75
Orthotopic liver transplantation for liver cirrhosis due to hepatitis C virus in patients with hemophilia A: two benefits of one procedure. Pol Arch Med Wewn (2014) 0.75
Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study. Transpl Int (2007) 0.75
[Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity]. Wiad Lek (2005) 0.75
[Use of preventive strategies by surgeons and HIV exposure]. Wiad Lek (2004) 0.75
[Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)]. Przegl Epidemiol (2008) 0.75
Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014. Przegl Epidemiol (2014) 0.75